Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 200 Total
NXE - NexGen Energy Ltd - Stock Price Chart
TickerNXE [NYSE]
CompanyNexGen Energy Ltd
CountryCanada
IndustryUranium
Market Cap3.88BEPS (ttm)0.07
P/E109.76EPS this Y-188.74%
Forward P/E-EPS next Y-2.10%
PEG-EPS past 5Y88.13%
P/S-EPS next 5Y-
P/B5.66EPS Q/Q-373.27%
Dividend-Sales Q/Q-
Insider Own8.45%Inst Own50.06%
Insider Trans0.00%Inst Trans-
Short Float9.29%EarningsMay 08/a
Analyst Recom1.12Target Price10.24
Avg Volume6.23M52W Range3.61 - 8.88
NexGen Energy Ltd. engages in the exploration and development of uranium properties. Its uranium project portfolio includes Arrow, South Arrow, Harpoon, Bow, IsoEnergy, SW1, SW2, SW3, and IsoEnergy properties. The company was founded by Leigh B. Curyer on March 8, 2011 and is headquartered in Vancouver, Canada.
SOAR - Volato Group Inc - Stock Price Chart
TickerSOAR [AMEX]
CompanyVolato Group Inc
CountryUSA
IndustryAirports & Air Services
Market Cap47.11MEPS (ttm)-3.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.64EPS next 5Y-
P/B3.06EPS Q/Q-5314.48%
Dividend-Sales Q/Q-
Insider Own49.64%Inst Own11.11%
Insider Trans0.02%Inst Trans6.23%
Short Float1.72%EarningsMay 15/b
Analyst Recom-Target Price-
Avg Volume45.66K52W Range1.75 - 35.00
Volato Group, Inc. is an aviation company, which engages in the provision of aircraft products and other services. The company was founded on January 7, 2021, and is headquartered in Chamblee, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Drucker SteveChief Technology OfficerMar 28 '24Option Exercise0.142,0002802,000Apr 19 09:05 PM
Liotta MatthewCEO and DirectorMar 28 '24Buy3.533,00010,5804,791,217Apr 02 12:39 PM
TFFP - Tff Pharmaceuticals Inc - Stock Price Chart
TickerTFFP [NASD]
CompanyTff Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap6.05MEPS (ttm)-12.68
P/E-EPS this Y54.77%
Forward P/E-EPS next Y4.66%
PEG-EPS past 5Y-13.86%
P/S-EPS next 5Y-
P/B0.48EPS Q/Q60.48%
Dividend-Sales Q/Q-
Insider Own1.74%Inst Own12.34%
Insider Trans0.00%Inst Trans9.29%
Short Float4.30%EarningsMar 28/a
Analyst Recom1.00Target Price24.50
Avg Volume37.14K52W Range1.96 - 19.75
May-01-24 05:07PM TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering (GlobeNewswire)
Apr-30-24 05:53AM TFF Pharmaceuticals Prices $4.8 Million Public Offering; Shares Down Pre-Bell (MT Newswires)
Apr-29-24 08:00PM TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering (GlobeNewswire) -7.24%
10:00AM TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting (GlobeNewswire)
Apr-15-24 07:00AM TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions (GlobeNewswire) -8.57%
Mar-28-24 10:54PM TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -8.35%
04:05PM TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-27-24 04:01PM TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs (GlobeNewswire)
Mar-25-24 09:01AM TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting (GlobeNewswire)
Mar-22-24 03:11PM TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -6.33%
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARLSON CAPITAL L P10% OwnerAug 16 '23Sale0.391,0003925,064,000Aug 17 05:29 PM
Weisman Harlan FPresident and CEOAug 15 '23Buy0.25600,000150,000814,615Aug 15 08:00 AM
Mikhak ZamanehChief Medical OfficerAug 15 '23Buy0.25120,00030,000135,000Aug 15 08:00 AM
MILLS ROBERT SDirectorAug 15 '23Buy0.2540,00010,00055,980Aug 15 08:00 AM
ROCAMBOLI STEPHENDirectorAug 15 '23Buy0.2520,0005,00036,000Aug 15 08:00 AM
RIOT - Riot Platforms Inc - Stock Price Chart
TickerRIOT [NASD, RUT]
CompanyRiot Platforms Inc
CountryUSA
IndustryCapital Markets
Market Cap2.66BEPS (ttm)0.73
P/E12.53EPS this Y137.53%
Forward P/E25.77EPS next Y241.50%
PEG0.63EPS past 5Y42.06%
P/S9.27EPS next 5Y20.00%
P/B1.00EPS Q/Q342.55%
Dividend-Sales Q/Q8.27%
Insider Own8.23%Inst Own36.55%
Insider Trans-0.45%Inst Trans6.06%
Short Float17.16%EarningsMay 01/b
Analyst Recom1.08Target Price18.22
Avg Volume25.70M52W Range7.80 - 20.65
Riot Platforms, Inc. is a bitcoin mining company engaged in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. The firm operates through following segments: Bitcoin Mining, Data Center Hosting, and Engineering. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Werner Ryan D.SVP, CAOMar 15 '24Sale11.1535,000390,250462,759Mar 19 09:04 PM
Cho HannahDirectorFeb 28 '24Sale17.4215,000261,30085,151Mar 01 08:59 PM
Jackman William RichardEVP, GENERAL COUNSELDec 08 '23Sale15.6857,000893,669947,557Dec 12 06:33 PM
Marleau HubertDirectorAug 17 '23Sale12.2851,165628,30627,860Aug 21 08:18 PM
D'Ambrosio Lance VarroDirectorJul 17 '23Sale19.1626,000498,16013,441Jul 19 06:51 PM
AGEN - Agenus Inc - Stock Price Chart
TickerAGEN [NASD, RUT]
CompanyAgenus Inc
CountryUSA
IndustryBiotechnology
Market Cap220.29MEPS (ttm)-12.62
P/E-EPS this Y35.33%
Forward P/E-EPS next Y2.78%
PEG-EPS past 5Y13.79%
P/S1.36EPS next 5Y-
P/B-EPS Q/Q29.41%
Dividend-Sales Q/Q22.28%
Insider Own4.95%Inst Own53.77%
Insider Trans102.04%Inst Trans-
Short Float16.22%EarningsMay 07/b
Analyst Recom1.20Target Price44.25
Avg Volume810.75K52W Range4.78 - 42.60
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARMEN GARO HSee RemarksFeb 15 '24Buy0.65500,000324,050625,969Feb 15 06:59 PM
WIINBERG ULFDirectorNov 15 '23Buy0.7625,00019,000124,063Nov 17 04:22 PM
AGENUS INC10% OwnerOct 16 '23Buy1.1042947221,772,863Oct 16 05:49 PM
AGENUS INC10% OwnerOct 13 '23Buy1.1019,37321,31021,772,434Oct 16 05:49 PM
AGENUS INC10% OwnerOct 12 '23Buy1.103,1733,48821,753,061Oct 16 05:49 PM
NIVF - NewGenIvf Group Ltd - Stock Price Chart
TickerNIVF [NASD]
CompanyNewGenIvf Group Ltd
CountryTaiwan
IndustryHealth Information Services
Market Cap4.77MEPS (ttm)-0.21
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.31EPS Q/Q-569.60%
Dividend-Sales Q/Q-
Insider Own-Inst Own33.84%
Insider Trans-Inst Trans2.25%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume6.46M52W Range0.63 - 17.24
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.
STEM - Stem Inc - Stock Price Chart
TickerSTEM [NYSE, RUT]
CompanyStem Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap193.98MEPS (ttm)-1.45
P/E-EPS this Y14.26%
Forward P/E-EPS next Y60.24%
PEG-EPS past 5Y-438.13%
P/S0.46EPS next 5Y-
P/B0.52EPS Q/Q-58.17%
Dividend-Sales Q/Q-62.21%
Insider Own6.98%Inst Own62.34%
Insider Trans-7.26%Inst Trans2.03%
Short Float24.52%EarningsMay 02/a
Analyst Recom2.33Target Price3.83
Avg Volume5.21M52W Range1.27 - 7.78
Stem, Inc. engages in the provision of an energy storage system, hardware, ongoing software platform and professional services, and solar asset performance monitoring and control. The company was founded in 2009 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carrington John EugeneCEO and DirectorMay 02 '24Sale1.85194,171359,216506,585May 07 07:49 AM
Russo AlanChief Revenue OfficerApr 30 '24Sale1.8724,14245,146212,910Apr 30 05:21 PM
BUSH WILLIAM JOHNChief Financial OfficerApr 30 '24Sale1.8724,03544,945390,217Apr 30 05:21 PM
Patel PrakeshChief Strategy OfficerApr 30 '24Sale1.8723,86344,624181,668Apr 30 05:22 PM
Laureles Saul R.Chief Legal OfficerApr 30 '24Sale1.878221,537150,990Apr 30 05:21 PM
KOSS - Koss Corp. - Stock Price Chart
TickerKOSS [NASD]
CompanyKoss Corp.
CountryUSA
IndustryConsumer Electronics
Market Cap29.58MEPS (ttm)-0.12
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.37EPS next 5Y-
P/B0.95EPS Q/Q-33.99%
Dividend-Sales Q/Q-21.71%
Insider Own43.64%Inst Own6.24%
Insider Trans0.00%Inst Trans1.01%
Short Float0.22%Earnings-
Analyst Recom-Target Price-
Avg Volume42.51K52W Range2.27 - 4.66
Koss Corp. engages in the design, manufacture and sale of stereo headphones and accessories. Its products include wireless, ear clip, over ear, and on ear earphones, Bluetooth speaker and cushions, cases, cables and apparel accessories. The company was founded by John C. Koss Sr. in 1958 and is headquartered in Milwaukee, WI.
BACK - IMAC Holdings Inc - Stock Price Chart
TickerBACK [NASD]
CompanyIMAC Holdings Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap3.91MEPS (ttm)-13.61
P/E-EPS this Y57.26%
Forward P/E-EPS next Y0.00%
PEG-EPS past 5Y10.09%
P/S0.46EPS next 5Y-
P/B-EPS Q/Q62.03%
Dividend-Sales Q/Q-58.64%
Insider Own18.10%Inst Own7.70%
Insider Trans0.00%Inst Trans-
Short Float18.53%Earnings-
Analyst Recom1.00Target Price8.00
Avg Volume1.01M52W Range1.22 - 7.75
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Franklin, TN.
CHRS - Coherus Biosciences Inc - Stock Price Chart
TickerCHRS [NASD, RUT]
CompanyCoherus Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap215.65MEPS (ttm)-0.79
P/E-EPS this Y83.32%
Forward P/E-EPS next Y35.81%
PEG-EPS past 5Y4.73%
P/S0.71EPS next 5Y-
P/B-EPS Q/Q185.78%
Dividend-Sales Q/Q137.58%
Insider Own1.94%Inst Own77.96%
Insider Trans-9.20%Inst Trans-1.46%
Short Float19.49%EarningsMay 09/a
Analyst Recom1.50Target Price8.33
Avg Volume2.24M52W Range1.43 - 6.16
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wahlstrom MatsDirectorFeb 01 '24Option Exercise1.6759,988100,00099,988Feb 05 07:03 PM
Lanfear Dennis MPresident & CEONov 22 '23Option Exercise1.42299,940425,015954,793Nov 24 04:04 PM
Lanfear Dennis MPresident & CEONov 22 '23Sale2.02223,100449,770731,693Nov 24 04:04 PM
134567891011121320